Publication Name	World Journal of Biological Chemistry
Manuscript ID	66353
Country	Japan

Received	2021-03-26 02:43
Peer-Review Started	2021-03-26 02:47
To Make the First Decision
Return for Revision	2021-05-06 00:20
Revised	2021-05-21 07:40
Second Decision	2021-11-26 03:32
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2021-11-28 08:13
Articles in Press	2021-11-28 08:13
Publication Fee Transferred
Edit the Manuscript by Language Editor	2021-11-22 00:07
Typeset the Manuscript	2021-11-29 02:29
Publish the Manuscript Online	2021-12-14 05:28

ISSN	1949-8454 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Neurosciences
Manuscript Type	Minireviews
Article Title	Neuroprotection by dipeptidyl-peptidase-4 inhibitors and glucagon-like peptide-1 analogs via the modulation of AKT-signaling pathway in Alzheimer’s disease
Manuscript Source	Invited Manuscript
All Author List	Yuka Ikeda, Nozomi Nagase, Ai Tsuji, Yasuko Kitagishi and Satoru Matsuda
Funding Agency and Grant Number
Corresponding Author	Satoru Matsuda, MD, PhD, Professor, Food Science and Nutrition, Nara Women's University, Kita-Uoya Nishimachi, Nara 630-8506, Japan. smatsuda@cc.nara-wu.ac.jp
Key Words	Alzheimer’s disease; Cognitive disorder; Dementia; Glucagon-like peptide-1; Dipeptidyl peptidase-4; Mammalian/mechanistic target of rapamycin
Core Tip	Disorders of mammalian/mechanistic target of rapamycin (mTOR) signaling pathways are related to Alzheimer’s disease (AD). Although further studies for mTOR, glucagon-like peptide-1, and dipeptidyl-peptidase-4 signaling are needed, they seem to be a promising approach for innovative AD-treatments.
Publish Date	2021-12-14 05:28
Citation	Ikeda Y, Nagase N, Tsuji A, Kitagishi Y, Matsuda S. Neuroprotection by dipeptidyl-peptidase-4 inhibitors and glucagon-like peptide-1 analogs via the modulation of AKT-signaling pathway in Alzheimer’s disease. World J Biol Chem 2021; 12(6) 104-113
URL	https://www.wjgnet.com/1949-8454/full/v12/i6/104.htm
DOI	https://dx.doi.org/10.4331/wjbc.v12.i6.104

Full Article (PDF)	WJBC-12-104.pdf
Full Article (Word)	WJBC-12-104.docx
Manuscript File	66353_Auto_Edited-CKL-Filipodia.docx
Answering Reviewers	66353-Answering reviewers.pdf
Audio Core Tip	66353-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	66353-Conflict-of-interest statement.pdf
Copyright License Agreement	66353-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	66353-Language certificate.pdf
Peer-review Report	66353-Peer-review(s).pdf
Scientific Misconduct Check	66353-Bing-Chang KL-2.png
Scientific Misconduct Check	66353-Bing-Ma YJ-1.jpg
Scientific Editor Work List	66353-Scientific editor work list.pdf